search
Back to results

Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery (MEIJE)

Primary Purpose

Hip Arthropathy Associated With Other Conditions

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Radiographs
Sponsored by
Groupe Hospitalier Diaconesses Croix Saint-Simon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Hip Arthropathy Associated With Other Conditions

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

An x-ray of the hip concerned will be performed on all consenting patients, having at least one criterion of the following three during their medical history since the implantation of the hip prosthesis.

  • Weight> 60 kg
  • DEVANE score ≥ 4
  • Long neck / varus

Exclusion Criteria:

  • The patient expresses his opposition to the use of his personal data
  • Patients (<18 years old)
  • Patients unable or out of state to express their consent
  • Patient unable to speak French
  • Patient with memory impairment or cognitive impairment
  • Patient not affiliated to a social security or equivalent health coverage

Sites / Locations

  • Groupe Hospitalier Diaconesses Croix Saint Simon
  • Groupe Hospitalier Dianconesses croix saint Simon
  • Groupe Hospitalier Diaconesses Croix saint Simon
  • Orthopedic department

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Patients implanted with Meije duo stem size 1 or 2

Arm Description

Among this arm, patients that meet criteria ( weight> 60kg and / or a long neck / varus and / or a DEVANE score ≥ 4 ) will perform hip X ray

Outcomes

Primary Outcome Measures

Pourcentage of participants who had stem (Meije DuoTM size 1 or 2) breakage occured between implantation and the study follow-up call phone.
The number of stem breakage that occured since prostheses implantation will be collected by asking every participant during the follow-up call phone and performing hip xray to eligible ones (see above)

Secondary Outcome Measures

Pourcentage of participants who had other prostheses failures (loosening of the prosthesis, femoral fracture, dislocation)
The number of prostheses failures that occured since the implantation will be collected by asking every participant during the follow-up call phone and by performing hip xray to eligible ones (see above)
The change of physical activity in participants from baseline (prostheses implantation) to study call-phone point time.
With DEVANE questionnaire, investigator will assess physical activity of participants
The change of the weight and the body mass index (BMI) of the patients after the implantation of Meije DuoTM rods size 1 or 2
Preoperative weight and BMI of particpantS will be collected from the medical file and postopeartive weight and BMI during follow up call phone

Full Information

First Posted
February 4, 2020
Last Updated
March 22, 2023
Sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon
search

1. Study Identification

Unique Protocol Identification Number
NCT04262713
Brief Title
Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery
Acronym
MEIJE
Official Title
Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
March 23, 2019 (Actual)
Primary Completion Date
July 12, 2021 (Actual)
Study Completion Date
April 11, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A normative development concerning the mechanical resistance tests of the the femoral stems led to contraindicate, in September 2014, to implant Meije Duo ™ femoral stems size 1 or 2 in patients weighing more than 60 kg due to an assumed risk of femoral stem breakage. This contraindication is based on standardized mechanical tests which may have not taken into account the changes in patient weight that may occur after the intervention. To date, investigators have not been aware of any Meije Duo ™ size 1/2 brakeage in our patients implanted with this type of prosthesis regardless of their weights before 2014. However, it is possible that some of them have had a prostheses failure and consulted another hospital. In the absence of a clinical study on this problem, investigators decided to set up a health care assessment study collecting retrospective and prospective information from our patients.
Detailed Description
First, patients with Meije Duo ™sizes 1 or 2, who had surgery from 2007 to 2014, will be preselected on medical records. The information notice will be sent to them by post. A period of reflection will be respected before contacting the patient to answer their questions concerning the research and its progress and obtain their oral consent to participate in the study. After obtaining consent, investigators will enter the retrospective data collected in the medical and prospective file collected during this call. Patients with at least one of the following criteria: weight> 60 kg and / or long neck / varus and / or DEVANE score ≥ 4, will be selected to have a hip X-ray which will be specially scheduled for the study. This examination will tell us about the state of the prosthesis and of the underlying bone (broken stem, loosening of the implant, bone fracture, dislocation, border, etc. It can be performed in our radiology department of the Diaconesses Croix Saint Simon hospital group or in another radiological center chosen by the patient if the latter cannot come to our hospital. In this case, a prescription for a hip X-ray will be sent to him by post to his current address as well as an information letter intended for the radiology office. The patients who will be included in the study are implanted with Meije Duo ™ 1 and 2 between 2007 to 2014 and will all have a minimum follow-up of 4 years from the date of implantation. The maximum number of rupture complications is observed between the fourth and the eleventh year after fitting the prosthesis. All participants will therefore have a minimum of hindsight required for the evaluation of stem breaks. All of our patients will be contacted by telephone during the study period in chronological order of their previous management for obtaining consent, prospective data and for scheduling the hip radiography according to the criteria mentioned above.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Arthropathy Associated With Other Conditions

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
256 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients implanted with Meije duo stem size 1 or 2
Arm Type
Other
Arm Description
Among this arm, patients that meet criteria ( weight> 60kg and / or a long neck / varus and / or a DEVANE score ≥ 4 ) will perform hip X ray
Intervention Type
Other
Intervention Name(s)
Radiographs
Intervention Description
Radiographs of the implanted hip with Meije duo size1 or 2 are performed in eligible patients ( Weigh>60, Long neck stem, Varus; DEVANE score ≥ 4)
Primary Outcome Measure Information:
Title
Pourcentage of participants who had stem (Meije DuoTM size 1 or 2) breakage occured between implantation and the study follow-up call phone.
Description
The number of stem breakage that occured since prostheses implantation will be collected by asking every participant during the follow-up call phone and performing hip xray to eligible ones (see above)
Time Frame
Up to 4 weeks, starting from the call phone (patient consent)
Secondary Outcome Measure Information:
Title
Pourcentage of participants who had other prostheses failures (loosening of the prosthesis, femoral fracture, dislocation)
Description
The number of prostheses failures that occured since the implantation will be collected by asking every participant during the follow-up call phone and by performing hip xray to eligible ones (see above)
Time Frame
Up to 4 weeks, starting from the call phone (patient consent)
Title
The change of physical activity in participants from baseline (prostheses implantation) to study call-phone point time.
Description
With DEVANE questionnaire, investigator will assess physical activity of participants
Time Frame
Change from baseline Devane score at postoperative 4 years
Title
The change of the weight and the body mass index (BMI) of the patients after the implantation of Meije DuoTM rods size 1 or 2
Description
Preoperative weight and BMI of particpantS will be collected from the medical file and postopeartive weight and BMI during follow up call phone
Time Frame
Change from baseline weight and BMI at postoperative 4 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: An x-ray of the hip concerned will be performed on all consenting patients, having at least one criterion of the following three during their medical history since the implantation of the hip prosthesis. Weight> 60 kg DEVANE score ≥ 4 Long neck / varus Exclusion Criteria: The patient expresses his opposition to the use of his personal data Patients (<18 years old) Patients unable or out of state to express their consent Patient unable to speak French Patient with memory impairment or cognitive impairment Patient not affiliated to a social security or equivalent health coverage
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Simon MARMOR, MD
Organizational Affiliation
Groupe Hospitalier Diaconesses Croix Saint-Simon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupe Hospitalier Diaconesses Croix Saint Simon
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75020
Country
France
Facility Name
Groupe Hospitalier Dianconesses croix saint Simon
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75020
Country
France
Facility Name
Groupe Hospitalier Diaconesses Croix saint Simon
City
Paris
ZIP/Postal Code
75020
Country
France
Facility Name
Orthopedic department
City
Paris
ZIP/Postal Code
75020
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18161256
Citation
Wroblewski BM, Siney PD, Fleming PA. Increasing patients' body mass. Are the criteria for testing stemmed femoral components in total hip arthroplasty still valid? Proc Inst Mech Eng H. 2007 Nov;221(8):959-61. doi: 10.1243/09544119JEIM305.
Results Reference
background
PubMed Identifier
12216021
Citation
Silva M, Shepherd EF, Jackson WO, Dorey FJ, Schmalzried TP. Average patient walking activity approaches 2 million cycles per year: pedometers under-record walking activity. J Arthroplasty. 2002 Sep;17(6):693-7. doi: 10.1054/arth.2002.32699.
Results Reference
background
PubMed Identifier
29608134
Citation
Westerman AP, Moor AR, Stone MH, Stewart TD. Hip stem fatigue: : The implications of increasing patient mass. Proc Inst Mech Eng H. 2018 May;232(5):520-530. doi: 10.1177/0954411918767200. Epub 2018 Apr 2.
Results Reference
result

Learn more about this trial

Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery

We'll reach out to this number within 24 hrs